Jump to main content
eTG Complete
eTG Complete
Index
  1. Home
  2. Addiction
  3. Stimulants: hazardous, harmful and dependent use
  4. Management of disorders of stimulant use in specific populations
  • Addiction
    • What is covered in the Addiction guidelines?
    • Overview of substance use and addictive behaviours
    • Tobacco smoking and nicotine dependence
    • Alcohol: hazardous, harmful and dependent use
    • Opioids: hazardous, harmful and dependent use
    • Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
    • Cannabis: hazardous, harmful and dependent use
    • Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
    • Hallucinogens: hazardous and harmful use
    • Ketamine: hazardous and harmful use
    • Pregabalin and gabapentin: hazardous, harmful and dependent use
    • Quetiapine and other antipsychotics: hazardous, harmful and dependent use
    • Sedating antihistamines: hazardous, harmful and dependent use
    • Stimulants: hazardous, harmful and dependent use
      • Overview of disorders of stimulant use
      • Harms of stimulant use
      • Screening and assessment of stimulant use
      • Overview of management of disorders of stimulant use
      • Management of stimulant withdrawal
      • Psychosocial interventions for long-term management of disorders of stimulant use
      • Management of disorders of stimulant use in specific populations
        • Management of disorders of stimulant use during pregnancy
        • Management of disorders of stimulant use during breastfeeding
      • References
    • Volatile inhalants: hazardous, harmful and dependent use
    • Addictive behaviours
    • Key resources for substance use and addictive behaviours

Management of disorders of stimulant use in specific populations

Specific considerations (including the need for specialist referral) apply in the management of stimulant use for people who are pregnant or breastfeeding. For other groups, see Considerations for specific populations in substance use and addictive behaviours.

  • Management of disorders of stimulant use during pregnancy
  • Management of disorders of stimulant use during breastfeeding
  • Contact us
  • Conditions of use and disclaimer
  • Privacy policy
  • Copyright permission
  • Support and FAQ

www.tg.org.au
All site content © Therapeutic Guidelines Limited 2020. Therapeutic Guidelines Limited, Ground Floor, 473 Victoria Street, West Melbourne, Victoria 3003, Australia © Therapeutic Guidelines Ltd (eTG August 2020)

Created: No created attribute found. Modified: No revised attribute found. (HW Diagnostics)